Difference between revisions of "Team:Oxford/Test/Safety3"
Line 1: | Line 1: | ||
− | + | <table> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<tr> | <tr> | ||
<th>Treatment</th> | <th>Treatment</th> | ||
Line 95: | Line 78: | ||
<td></td> | <td></td> | ||
</tr> | </tr> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− |
Revision as of 14:19, 27 August 2015
Treatment | Pros | Cons |
---|---|---|
Antibiotics | effective against many common infections | not effective against biofilms |
easy to administer | bacteria can develop resistance | |
few side effects | some can result in side effects that exaggerate initial symptoms | |
inexpensive | can cause severe allergic reactions | |
Catheter coated with silver nanoparticles | bacteria cannot develop resistance | there can be serious side effects |
uninvasive in those who would otherwise be having a catheter fitted anyway | catheters support biofilm formation which can lead to recurring infections | |
Botox | increases comfort by lessening symptoms of incontinence | does not treat underlying infection |
may need to have a catheter fitted which increases incidence of infection | ||
long term effect unknown | ||
invasive | ||
Methenamine hippurate | bacteria can’t develop resistance | have to take doses every day to prevent infection |
requires additional supplements for effective treatment (Vitamin C, Cranberry supplements) | ||
relatively new treatment which hasn’t been tested in children, the elderly, or breastfeeding women, so this limits the number of cases it can be prescribed in | ||
solUTIon | offers attack and defence against biofilm formation | as yet, untested in humans. there may be some unforeseen side effects |
bacteria cannot develop resistance | ||
relatively uninvasive | ||
acts against more than one species of bacteria and fungi |